WallStreetZenWallStreetZen

NASDAQ: GOSS
Gossamer Bio Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Gossamer Bio revenue was $114.70M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $9.4M, down 1.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GOSS annual revenue was $114.7M, with Infinity% growth year-over-year.

GOSS revenue history

Current Revenue
$114.7M
Current Earnings
-$56.5M
Current Profit Margin
-49.3%

Be the first to know when GOSS announces revenue.

GOSS Revenue History By Year

GOSS Yearly RevenueGOSS RevenueGOSS ChangeGOSS Revenue Growth
2024-12-31$114.70MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Gossamer Bio Revenue FAQ

What was GOSS's revenue last quarter?

On Invalid Date, Gossamer Bio (NASDAQ: GOSS) reported Q4 2024 revenue of $9.38 million up Infinity% year over year. In the same quarter last year, Gossamer Bio's revenue was $0.00.

What was Gossamer Bio's revenue in 2024?

Gossamer Bio's annual revenue for the twelve months ending Dec 31, 2024 was $114.70 million, a Infinity% increase year over year.

How much does Gossamer Bio make in a day?

Based on Gossamer Bio annual revenue for the past five years, GOSS makes an average of $62,849.86 per day.

What was Gossamer Bio's annual revenue growth in the past year?

As of Q2 2025, Gossamer Bio's revenue has grown null year over year. Gossamer Bio's revenue in the past year totaled $114.70 million.

How much does Gossamer Bio make in a year?

Gossamer Bio's revenue by year for the past five years is:
  • Gossamer Bio's revenue for the twelve months ending Dec 31, 2024 was $114.70 million, a Infinity% increase year over year.
  • Gossamer Bio's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Gossamer Bio's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Gossamer Bio's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Gossamer Bio's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.